Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
    • The Bookshelf
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • POCUS
    • Literature Lounge
    • History of HM
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Career
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
    • The Bookshelf
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Learning
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Nephrology (kidneys)

  • Article

    Continuing SGLT2 Inhibitors After Urinary Tract Infection

    October 1, 2026

    Clinical Question: Do SGLT2 inhibitors need to be discontinued in patients with type 2 diabetes mellitus (T2DM) who develop a urinary tract infection (UTI), and what are the clinical implications...

  • Article

    Oral Antithrombotic Monotherapy Is as Effective as Dual Therapy and Likely Safer in Advanced Kidney Disease

    October 1, 2026

    Clinical Question: Is oral anticoagulant monotherapy safer and more effective than dual antithrombotic therapy in patients with atrial fibrillation (AF), coronary artery disease (CAD), and advanced...

  • Article

    Targeted Inpatient Correction of Chronic Hyponatremia Does Not Improve Short-Term Clinical Outcomes

    September 2, 2026

    Clinical Question: Does targeted correction of chronic hyponatremia in hospitalized patients reduce 30-day mortality or rehospitalization compared with routine care? Background: Chronic hyponatremia...

  • Article

    Discontinuation of ACEIs/ARBs During AKI in Hospitalized Patients Decreases All-Cause Mortality

    September 2, 2026

    Clinical Question: Does discontinuation of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) during an episode of acute kidney injury (AKI) improve clinical...

  • Article

    Daily Fish-Oil Supplementation Reduced Serious Cardiovascular Events in Patients with End-Stage Kidney Disease Who Receive Maintenance Hemodialysis

    September 2, 2026

    Clinical Question: Does daily supplementation with omega-3 polyunsaturated fatty acids reduce cardiovascular events in patients on maintenance hemodialysis? Background: Cardiovascular disease is the...

  • Article

    Sodium Bicarbonate for Severe Metabolic Acidemia and Acute Kidney Injury: BICARICU-2

    June 18, 2026

    Mount Sinai Med-Lit Review Clinical question: Does sodium bicarbonate infusion in patients with moderate to severe acute kidney injury and severe metabolic acidosis reduce 90-day all-cause...

  • Article

    Predicting Contrast-Associated AKI

    May 1, 2026

    Clinical question: Do newer prediction models pooled in a systematic review predict contrast-associated acute kidney injury (CA-AKI)? Background: This systematic review updates a previous evaluation...

  • Article

    Sodium Bicarbonate Does Not Reduce 90-Day Mortality in Severe Metabolic Acidemia with AKI

    May 1, 2026

    Clinical question: In critically ill adults with severe metabolic acidemia and moderate to severe acute kidney injury (AKI), does intravenous sodium bicarbonate reduce 90-day all-cause...

  • Article

    What’s New in the 2025 IDSA Updates for Complicated UTIs?

    April 6, 2026

    Case: An 80-year-old man with Alzheimer’s dementia presents with fever, worsening suprapubic discomfort, and new right flank pain. He began ciprofloxacin the day before for a presumed urinary tract...

  • Article

    Limited Access to Pre-Dialysis Care Associated with Lower Rates of Usable AV Dialysis Access at Dialysis Initiation for Hispanic Patients

    March 2, 2026

    CLINICAL QUESTION: Is there a relationship between access to pre-dialysis nephrology care and the presence of usable arteriovenous (AV) access at dialysis initiation among Hispanic...

1 2 3 … 10Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • Cookie Preferences